Marisa Papaluca on Personalised Medicine Regulatory Issues

September 2016 12 minutes English

Interview with Marisa Papaluca, Senior Scientific Advisor, European Medicines Agency (EMA)

At ECRIN's International Clinical Trials Day (ICTD) 2016 meeting in Prague, Czech Republic, Marisa Papaluca responded to the following:

  • What are the main regulatory pathways and challenges for personalised medicine in Europe?
  • Can you provide a specific example of a regulatory issue and how it was resolved?